300 | 29 bc | 150 | 29 bc | 107 | 36 b |
400 | 30 bc | 200 | 29 bc | 108 | 31 c |
500 | 27 cd | 250 | 25 cd | 109 | 24 cd |
600 | 27 cd | 300 | 19 de |
|
|
700 | 18 de | 350 | 13 ef |
|
|
800 | 10 f | 400 | 7 f |
|
|
900 | 5 f | 450 | 7 f |
|
|
LSD | 5.6 |
|
|
|
|
Regression | y = −0.037x + 42.67 |
| y = −0.08x + 42.81 |
| y = −1.98x + 47.88 |
r2 | 0.91 |
| 0.95 |
| 0.67 |
Effective dose (ED50) | 577 µg∙ml−1 | 267 µg∙ml−1 |
|
|
|
| Gray mould disease severity (%) |
|
|
|
|
0 | 85 a | 0 | 85 a | 0 | 85 a |
200 | 85 a | 200 | 80 b | 105 | 85 a |
400 | 80 a | 400 | 65 c | 106 | 80 a |
600 | 70 b | 600 | 53 c | 107 | 74 ab |
800 | 55 c | 800 | 35 d | 108 | 65 bc |
1000 | 30 d | 1000 | 20 f | 109 | 55 c |
LSD |
|
|
|
| 12.5 |
Regression | y = −0.05x + 94.28 |
| y = −0.06x + 90.04 |
| y = −2.99x + 91.44 |
r2 | 0.85 |
| 0.98 |
| r² = 0.63 |
Effective dose (ED50) | 943 µg∙ml−1 |
| 750 µg∙ml−1 |
|
|